The Impact of AVATAR Therapy on Voice Hearing in Everyday Life: ESM Outcomes of the AVATAR2 Trial
Year: 2025
Type: article
Abstract: AVATAR therapy involves facilitated dialogs between a voice hearer and a digital embodiment of their distressing voice ("the avatar"). We conducted a multi-site single-blind randomized controlled trial to evaluate the efficacy of brief (AV-BRF) and extended (AV-EXT) forms of AVATAR therapy, compared with treatment as usual (TAU) alone (AVATAR2). This study reports the data from experience sampling method (ESM) assessments conducted at baseline, end of therapy (16 weeks), and follow-up (28 weeks). The research questions focused on whether those in the AV-BRF or AV-EXT arms experienced less voice-related distress, anxiety, and beliefs as measured by ESM, compared to TAU. Separate mixed-effects models were fitted for each research question. The final sample (n = 200) completed approximately 40% of questionnaires across all timepoints. Participants who received AV-EXT therapy, but not AV-BRF, reported reduced momentary voice-related distress at 16 (P = .022) and 28 weeks (p = .029). Appraisals of voice control were also reduced in the AV-EXT arm at 16 weeks when the voice was present (P = .002) or not (P = .008). Voice power appraisals were reduced (P < .035) in both arms when the voice was "not present but on my mind" at all timepoints. There were no changes in the frequency of voice hearing, appraisals of voice intent, or assertive responding. These findings from everyday life, reported for the first time, provide evidence of the impact on the primary AVATAR therapy treatment targets, including appraisals of voice power and control. The weight of evidence favors the AV-EXT protocol in the further development and implementation of AVATAR therapy.
Source: Schizophrenia Bulletin
Authors: Clementine J Edwards, Robin Smith, Ginette Lafit, Thomas Ward, Richard Emsley, Mar Rus-Calafell, Inez Myin-Germeys, Emmanuelle Peters, Sandra Bucci, Thomas K Craig, Gillian Haddock, Hannah Ball, Miriam Fornells-Ambrojo, Amy Hardy, Hamish McLeod, Andrew I Gumley, Jeffrey McDonnell, Alice Montague, Moya Clancy, Mark Huckvale, Philippa Anne Garety
Institutions: King's College London, South London and Maudsley NHS Foundation Trust, KU Leuven, Ruhr University Bochum, Greater Manchester Mental Health NHS Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, North East London NHS Foundation Trust, University College London, NHS Greater Glasgow and Clyde, University of Glasgow
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,981
Awards: G1066719608, G125566990, G1412918328, G1483213741, G1798610363, Optimising AVATAR therapy for distressing voices: a multi-centre randomised controlled trial, Optimising AVATAR therapy for distressing voices: a multi-centre randomised controlled trial, Digital solutions for people with severe mental health problems, Design and analysis of efficient randomised trials in mental health, G5421741861, G7899740451
OpenAlex ID: W4417352363
